Belgian molecular diagnostics company Biocartis Group said on Thursday it had entered into an agreement with British drugmaker AstraZeneca to obtain faster lung cancer molecular diagnostic biomarker results in Europe.
from Latest News https://ift.tt/2E5DSRx
Biocartis partners with AstraZeneca on lung cancer diagnostics
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment